QSS
SRPT icon

Quantitative Systematic Strategies’s Sarepta Therapeutics SRPT Stock Holding History

Quantitative Systematic Strategies’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,712
Closed -$412K – 577
2019
Q2 		$412K Buy
+2,712
New +$330K 0.08% 285
2018
Q4 		– Sell
-3,113
Closed -$503K – 853
2018
Q3 		$503K Buy
3,113
+682
+28% +$93.2K 0.1% 305
2018
Q2 		$321K Sell
2,431
-1,098
-31% -$104K 0.06% 451
2018
Q1 		$261K Buy
+3,529
New +$235K 0.06% 496
2016
Q4 		– Sell
-3,312
Closed -$202K – 412
2016
Q3 		$202K Sell
3,312
-7,981
-71% -$241K 0.07% 334
2016
Q2 		$211K Buy
+11,293
New +$209K 0.1% 273
2016
Q1 		– Sell
-7,934
Closed -$311K – 729
2015
Q4 		$311K Buy
+7,934
New +$257K 0.08% 362
2015
Q3 		– Sell
-10,291
Closed -$295K – 518
2015
Q2 		$295K Buy
+10,291
New +$210K 0.07% 420

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Quantitative Systematic Strategies's SRPT Position: Q3 2019 in Review

Quantitative Systematic Strategies sold out of Sarepta Therapeutics (SRPT) in Q3 2019, closing a stake of 2,712 shares — an estimated $412K sold.

Quantitative Systematic Strategies first reported a position in SRPT in Q2 2015 and held it in 8 quarters. The position peaked at $503K in Q3 2018. 340 funds tracked by Wall St. Rank hold SRPT as of Q3 2019.

  • Quantitative Systematic Strategies reported no remaining Sarepta Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 2,712 Sarepta Therapeutics shares in Q3 2019, an estimated $412K.
  • Quantitative Systematic Strategies first reported a position in Sarepta Therapeutics in Q2 2015 and held it in 8 quarters.
  • Quantitative Systematic Strategies's Sarepta Therapeutics position peaked at $503K in Q3 2018.
  • 340 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2019, filed 7 Nov 2019.